Grants & Projects per year
Personal profile
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
BioNTech SE: A Phase I/II, multi-site, open-label, two-part trial to evaluate the efficacy, safety, and pharmacokinetics of BNT323 in combination with BNT327 in participants with advanced breast cancer
Almanzar, L. C. (CoI), Andrzejczyk, A. (CoI), Baer, L. (CoI), Cohen, J. A. (CoI) & Stopeck, A. (CoI)
04/29/26 → 01/17/27
Project: Research
-
Biostar: BG01-2402: A Pivotal Phase II Clinical Trial of Utidelone Injection (UTD1) Plus Capecitabine (CAP) in HER2- negative Breast Cancer Patients with Brain Metastases
Andrzejczyk, A. (CoI), Baer, L. (CoI), Cohen, J. A. (CoI) & Stopeck, A. (CoI)
04/10/26 → 12/5/26
Project: Research
-
ICON: A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC determined...
Andrzejczyk, A. (CoI), Baer, L. (CoI), Cohen, J. A. (CoI) & Stopeck, A. (CoI)
02/27/26 → 10/3/26
Project: Research
-
Nektar Therapeutics: A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated...
Baer, L. (PI), Cohen, J. A. (CoPI), Stopeck, A. (CoPI) & Kudelka, A. (CoPI)
12/7/17 → 07/19/18
Project: Research
-
MonarchE: A Randomized Open-Label Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk Node Positive Early Stage Hormone Receptor Positive
Baer, L. (CoI), Cohen, J. A. (CoI) & Stopeck, A. (CoI)
11/7/17 → 07/31/26
Project: Research
-
Metastatic breast cancer through the Oncotype DX Breast Recurrence Score®: insights from a small cohort study
Gemmill, J. A. L., Thompson, P., Batiste, R., Vacchi-Suzzi, C., Preece, C., Cohen, J., Baer, L., Mies, C., Turner, M., Russell, C. A. & Stopeck, A., Jul 2025, In: Breast Cancer Research and Treatment. 212, 2, p. 407-413 7 p.Research output: Contribution to journal › Article › peer-review
-
Development of a Radiolabeled Cyclin-Dependent Kinases 4 and 6 (CDK4/6) Inhibitor for Brain and Cancer PET Imaging
Huang, C. H., Khan, P., Xu, S., Cohen, J., Georgakis, G. V. & Turkman, N., Jul 2024, In: International Journal of Molecular Sciences. 25, 13, 6870.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Utility of Stereotactic Body Radiation Therapy in Establishing Local Control for Patients With Invasive Breast Cancer Not Undergoing Definitive Surgery
Zabrocka, E., Polce, S., Roberson, J. D., Wu, J., Cohen, J., Baer, L., Stopeck, A., Ryu, S. & Stessin, A., Feb 1 2024, In: International Journal of Radiation Oncology, Biology, Physics. 118, 2, p. 436-442 7 p.Research output: Contribution to journal › Article › peer-review
10 Scopus citations -
Synthesis and Preclinical Evaluation of a Novel Fluorine-18-Labeled Tracer for Positron Emission Tomography Imaging of Bruton's Tyrosine Kinase
Li, K., Wang, M., Akoglu, M., Pollard, A. C., Klecker, J. B., Alfonso, P., Corrionero, A., Prendiville, N., Qu, W., Parker, M. F. L., Turkman, N., Cohen, J. A. & Tonge, P. J., Mar 10 2023, In: ACS Pharmacology and Translational Science. 6, 3, p. 410-421 12 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Blood plasma derived extracellular vesicles (BEVs): particle purification liquid chromatography (PPLC) and proteomic analysis reveals BEVs as a potential minimally invasive tool for predicting response to breast cancer treatment
Alvarez, F. A., Kaddour, H., Lyu, Y., Preece, C., Cohen, J., Baer, L., Stopeck, A. T., Thompson, P. & Okeoma, C. M., Nov 2022, In: Breast Cancer Research and Treatment. 196, 2, p. 423-437 15 p.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations